Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hahn

Showing results (1161-1170 of 1,198) with videos related to

Pageof 120
Sort By:
Frontiers in Oncology|November 28, 2022
Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinomaDeepika Dhawan, José A Ramos-Vara, Sagar M Utturkar, et al.
British Journal of Cancer|May 17, 2018
Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)Jonathan E Rosenberg, Noah M Hahn, Meredith M Regan, et al.
Urologic Oncology|June 9, 2018
Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy."D E Thomas, H Z Kaimakliotis, K R Rice, et al.
ACS Chemical Biology|April 26, 2013
An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1Kyle D Konze, Anqi Ma, Fengling Li, et al.
Nature Neuroscience|April 24, 2012
Rac1 is essential in cocaine-induced structural plasticity of nucleus accumbens neuronsDavid M Dietz, Haosheng Sun, Mary Kay Lobo, et al.
Cancer|August 7, 2020
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancerTian Zhang, Michael R Harrison, Peter H O'Donnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid TumorsCorey C Foster, Gini F Fleming, Theodore G Karrison, et al.
Journal of Clinical Microbiology|May 18, 2022
Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1Kyle G Rodino, David R Peaper, Brendan J Kelly, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome AnalysisBurles A Johnson Iii, Benjamin A Teply, Catherine Kagemann, et al.
Clinical Genitourinary Cancer|January 2, 2017
Prognostic Effect of Carcinoma In Situ in Muscle-invasive Urothelial Carcinoma Patients Receiving Neoadjuvant ChemotherapyDerek E Thomas, Hristos Z Kaimakliotis, Kevin R Rice, et al.
Pageof 120

Showing results (1161-1170 of 1,198) with videos related to

Sort By:
Pageof 120
Frontiers in Oncology|November 28, 2022
Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinomaDeepika Dhawan, José A Ramos-Vara, Sagar M Utturkar, et al.
British Journal of Cancer|May 17, 2018
Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)Jonathan E Rosenberg, Noah M Hahn, Meredith M Regan, et al.
Urologic Oncology|June 9, 2018
Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy."D E Thomas, H Z Kaimakliotis, K R Rice, et al.
ACS Chemical Biology|April 26, 2013
An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1Kyle D Konze, Anqi Ma, Fengling Li, et al.
Nature Neuroscience|April 24, 2012
Rac1 is essential in cocaine-induced structural plasticity of nucleus accumbens neuronsDavid M Dietz, Haosheng Sun, Mary Kay Lobo, et al.
Cancer|August 7, 2020
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancerTian Zhang, Michael R Harrison, Peter H O'Donnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid TumorsCorey C Foster, Gini F Fleming, Theodore G Karrison, et al.
Journal of Clinical Microbiology|May 18, 2022
Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1Kyle G Rodino, David R Peaper, Brendan J Kelly, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome AnalysisBurles A Johnson Iii, Benjamin A Teply, Catherine Kagemann, et al.
Clinical Genitourinary Cancer|January 2, 2017
Prognostic Effect of Carcinoma In Situ in Muscle-invasive Urothelial Carcinoma Patients Receiving Neoadjuvant ChemotherapyDerek E Thomas, Hristos Z Kaimakliotis, Kevin R Rice, et al.
Pageof 120